Company Summary

Anyone can benefit from Photetica's phototherapy based patented technology however the company is primarily focused on solving peripheral nervous and immune system problems. The focus is on patients undergoing chemotherapy Diabetics, and those with AIDS. We are the only company to successfully treat and prevent CIPN (chemotherapy induced peripheral neuropathy), 35% of chemotherapy patients get CIPN; 70% of Diabetics and AIDS patients get PN.